WHO SARS-CoV-2 Test Kit Comparative Study

In December, 2020 WHO issued an expression of interest to manufacturers of antibody detection assays to participate in a large comparative assessment being conducted at the NRL, a WHO Collaborating Centre and authorised WHO IVD Prequalification Evaluation Laboratory, and in cooperation with other partners including FIND, Erasmus Medical Centre, Duke NUS Singapore and the International Vaccines Institute.

The evaluation protocol was designed to assess the performance characteristics of the In-vitro diagnostics devices (IVDs) using a large and diverse set of carefully selected samples (WHO).

The table below presents a summary of all of the evaluation results, test kit information and study report

For further information, please email [email protected] and [email protected]